News
TipRanks on MSN3h
Ascendis Pharma price target raised to $216 from $201 at BofABofA raised the firm’s price target on Ascendis Pharma (ASND) to $216 from $201 and keeps a Buy rating on the shares. The firm notes the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback